Edition:
United States

Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

2.65USD
26 Sep 2016
Change (% chg)

$-0.10 (-3.64%)
Prev Close
$2.75
Open
$2.80
Day's High
$2.90
Day's Low
$2.53
Volume
785,069
Avg. Vol
644,939
52-wk High
$16.63
52-wk Low
$1.23

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.84 December 27 Sep 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 2 28.75 30.50 27.00 78.56
Quarter Ending Dec-16 2 31.75 32.50 31.00 82.25
Year Ending Dec-16 2 140.85 143.70 138.00 282.38
Year Ending Dec-17 2 152.50 155.00 150.00 334.52
Earnings (per share)
Quarter Ending Sep-16 2 -0.84 -0.68 -1.00 -0.01
Quarter Ending Dec-16 2 -0.50 -0.50 -0.51 -0.05
Year Ending Dec-16 1 -5.28 -5.28 -5.28 -1.29
Year Ending Dec-17 2 -1.16 -1.04 -1.28 -0.02

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 35.50 44.53 9.03 25.44
Quarter Ending Mar-16 43.00 35.72 7.28 16.94
Quarter Ending Dec-15 47.74 49.00 1.26 2.65
Quarter Ending Sep-15 59.59 67.30 7.71 12.94
Quarter Ending Jun-15 58.98 64.20 5.22 8.84

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 28.75 28.75 30.50 29.75 78.56
Quarter Ending Dec-16 31.75 31.75 32.50 33.75 82.25
Year Ending Dec-16 140.85 140.85 143.70 134.85 282.38
Year Ending Dec-17 152.50 152.50 155.00 153.00 334.52

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 0 0
Quarter Ending Dec-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Wright Reports
$75.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.